Inhibition of tumour growth by lipoxygenase inhibitors
1996

Inhibition of Tumour Growth by Lipoxygenase Inhibitors

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): HJ Hussey, MJ Tisdale

Primary Institution: Pharmaceutical Sciences Institute, Aston University

Hypothesis

The study investigates the role of lipoxygenase metabolites in the growth of tumours stimulated by arachidonic and linoleic acid.

Conclusion

The study found that lipoxygenase inhibitors can effectively inhibit the growth of certain murine adenocarcinomas.

Supporting Evidence

  • BWA4C and BWB70C were effective inhibitors of murine adenocarcinoma growth.
  • Zileuton was less effective compared to BWA4C and BWB70C.
  • IC50 values for BWA4C and BWB70C were less than 10 µM.
  • BWA4C significantly reduced MAC26 tumour volume at doses of 5 to 25 mg/kg.
  • Lower doses of BWB70C were ineffective or stimulated tumour growth.

Takeaway

Some medicines can help stop cancer from growing by blocking certain fats in the body.

Methodology

The study used in vitro and in vivo experiments with murine adenocarcinoma cell lines and lipoxygenase inhibitors.

Limitations

The study primarily focused on murine models, which may not fully represent human cancer biology.

Participant Demographics

Male NMRI mice, average body weight 25-30 g, age 6 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication